The Finnish competition regulator has approved Mehiläinen's acquisition of Vetrea's residential care business, showing that the big groups can still push for greater market share.
Biogroup, the fast consolidator of the French lab market, has moved into the Iberian peninsular for the first time by acquiring two assets: Analiza and Cerba Internacional. HBI hears the multiple looks very, very low.
Romania's largest healthcare provider Medlife says it has Balkan ambitions while acquiring half of regional oncology provider Neolife. The emergence of pan-EU players continues after the infrastructure investor that earlier bought Medipass, has bought a 14+ clinic network in Germany.
US-based pharmacy group McKesson has sold its UK arm - made up of retail pharmacy group Lloyds Pharmacy and a drug distribution business - to Aurelius, an investor specialised in turnarounds. The new owner is likely to focus on the rationalisation of the business, HBI hears.
Dallah Healthcare Company, a listed Saudi Arabian healthcare operator, has signed an agreement to buy 8.2% of the shares of a hospital in Jeddah, International Medical Centre (IMC). The move is part of Dallah Healthcare’s plan to gain a more than 25% stake in the hospital and increase its presence in Jeddah.
Two more dentistry platforms have been grabbed by two different private equity firms. NHS focused UK dental group Rodericks Dental has sold, HBI hears from multiple sources, and so has German-based KonfiDents. We name the buyers, the multiple, and consider why this development might shake up a stagnating market.
The more you look at the Babylon SPAC deal, the more black box it looks. The sheer complexity of the US insurance system makes it impossible for investors to assess its prospects with any accuracy. And then there is the question of the $230m sale of shares made by "certain accredited investors". How much of this went to Babylon founder Ali Parsa?
DomusVi, the third largest French nursing home group in France by revenue, has consolidated its position in the South-East of France and Corsica through the acquisition of the Medeos group. We speak to a consultant to find out what this means for the group in the region.
HBI understands that Montagu, owners of Artemis Augenkliniken which is Germany’s second-largest ophthalmology chain by revenue, is in bilateral talks to sell. HBI names the potential buyer, and also has a delve into the ongoing sale - and current finances - of Veonet Group.
Healthcare Business International users cookies to improve the functionality, performance, and effectiveness of our communications. Detailed information on the use of cookies is provided in our Cookies Policy. By continuing to use this site, or by clicking "I agree" you consent to the use of cookies.
